EP1085869A4 - Spiropiperidine derivatives as melanocortin receptor agonists - Google Patents
Spiropiperidine derivatives as melanocortin receptor agonistsInfo
- Publication number
- EP1085869A4 EP1085869A4 EP99930220A EP99930220A EP1085869A4 EP 1085869 A4 EP1085869 A4 EP 1085869A4 EP 99930220 A EP99930220 A EP 99930220A EP 99930220 A EP99930220 A EP 99930220A EP 1085869 A4 EP1085869 A4 EP 1085869A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- receptor agonists
- melanocortin receptor
- spiropiperidine derivatives
- spiropiperidine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8890898P | 1998-06-11 | 1998-06-11 | |
US88908P | 1998-06-11 | ||
GB9817179 | 1998-08-06 | ||
GBGB9817179.6A GB9817179D0 (en) | 1998-08-06 | 1998-08-06 | Spiropiperidine derivatives as melanocortin receptor agonists |
US12326099P | 1999-03-08 | 1999-03-08 | |
US123260P | 1999-03-08 | ||
PCT/US1999/013252 WO1999064002A1 (en) | 1998-06-11 | 1999-06-10 | Spiropiperidine derivatives as melanocortin receptor agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1085869A1 EP1085869A1 (en) | 2001-03-28 |
EP1085869A4 true EP1085869A4 (en) | 2001-10-04 |
Family
ID=27269429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99930220A Withdrawn EP1085869A4 (en) | 1998-06-11 | 1999-06-10 | Spiropiperidine derivatives as melanocortin receptor agonists |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1085869A4 (en) |
JP (1) | JP2002517444A (en) |
AU (1) | AU742425B2 (en) |
CA (1) | CA2334551A1 (en) |
WO (1) | WO1999064002A1 (en) |
Families Citing this family (147)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002064091A2 (en) | 2001-02-13 | 2002-08-22 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
CA2377369A1 (en) | 1999-06-04 | 2000-12-14 | Merck & Co., Inc. | Substituted piperidines as melanocortin-4 receptor agonists |
US7176279B2 (en) | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
US6579968B1 (en) | 1999-06-29 | 2003-06-17 | Palatin Technologies, Inc. | Compositions and methods for treatment of sexual dysfunction |
US6699873B1 (en) | 1999-08-04 | 2004-03-02 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
BR0012984A (en) * | 1999-08-04 | 2002-07-16 | Millennium Pharm Inc | Method for treating a condition associated with mc4-r in a mammal, compound binding to mc4-r, and pharmaceutical composition |
US7375125B2 (en) | 1999-08-04 | 2008-05-20 | Ore Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
AU2004202804B2 (en) * | 1999-08-04 | 2009-01-29 | Ore Pharmaceuticals Inc. | Melanocortin-4 Receptor Binding Compounds and Methods of use thereof |
GB0002059D0 (en) * | 2000-01-28 | 2000-03-22 | Melacure Therapeutics Ab | Novel aromatic amines |
AU2001228681A1 (en) * | 2000-01-28 | 2001-08-07 | Melacure Therapeutics Ab | Novel aromatic amines and amides acting on the melanocortin receptors |
CA2403686C (en) * | 2000-03-23 | 2010-01-26 | Merck & Co., Inc. | Substituted piperidines as melanocortin receptor agonists |
WO2001070337A1 (en) * | 2000-03-23 | 2001-09-27 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
US6600015B2 (en) | 2000-04-04 | 2003-07-29 | Hoffmann-La Roche Inc. | Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity |
AU2001264977B2 (en) * | 2000-05-30 | 2005-04-14 | Merck & Co., Inc. | Melanocortin receptor agonists |
WO2002000259A1 (en) | 2000-06-27 | 2002-01-03 | Taisho Pharmaceutical Co., Ltd. | Remedial agent for anxiety neurosis or depression and piperazine derivative |
EA200201119A1 (en) * | 2000-06-28 | 2003-06-26 | Пфайзер Продактс Инк. | LIGANDS OF MELANOCORTIN RECEPTORS |
GB0019357D0 (en) | 2000-08-07 | 2000-09-27 | Melacure Therapeutics Ab | Novel phenyl guanidines |
GB0019359D0 (en) | 2000-08-07 | 2000-09-27 | Melacure Therapeutics Ab | Novel guanidines |
AU2001288285B2 (en) | 2000-08-23 | 2005-09-29 | Merck & Co., Inc. | Substituted piperidines as melanocortin receptor agonists |
DZ3415A1 (en) * | 2000-08-31 | 2002-03-07 | Chiron Corp | GUANIDINOBENZAMIDES AS MC4-R AGONISTS. |
EP1358163A1 (en) | 2001-01-23 | 2003-11-05 | Eli Lilly And Company | Melanocortin receptor agonists |
DE60205727T2 (en) * | 2001-01-23 | 2006-06-29 | Eli Lilly And Co., Indianapolis | PIPERAZINE AND PIPERIDINE DERIVATIVES AS AGONISTS OF THE MELANOCORTIN RECEPTOR |
EP1368339A1 (en) | 2001-01-23 | 2003-12-10 | Eli Lilly & Company | Substituted piperidines/piperazines as melanocortin receptor agonists |
EP1363890A4 (en) * | 2001-02-07 | 2009-06-10 | Ore Pharmaceuticals Inc | Melanocortin-4 receptor binding compounds and methods of use thereof |
WO2002067869A2 (en) | 2001-02-28 | 2002-09-06 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
KR20030076716A (en) | 2001-02-28 | 2003-09-26 | 머크 앤드 캄파니 인코포레이티드 | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
CA2437594A1 (en) | 2001-03-02 | 2002-09-12 | Graham S. Poindexter | Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
US7456183B2 (en) | 2001-04-09 | 2008-11-25 | Novartis Vaccines And Diagnostics, Inc. | Guanidino compounds |
US6911447B2 (en) | 2001-04-25 | 2005-06-28 | The Procter & Gamble Company | Melanocortin receptor ligands |
US6809104B2 (en) | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
WO2002094825A1 (en) * | 2001-05-22 | 2002-11-28 | Banyu Pharmaceutical Co., Ltd. | Novel spiropiperidine derivative |
AU2002320494B2 (en) | 2001-07-18 | 2006-06-29 | Merck Sharp & Dohme Corp. | Bridged piperidine derivatives as melanocortin receptor agonists |
US7115607B2 (en) * | 2001-07-25 | 2006-10-03 | Amgen Inc. | Substituted piperazinyl amides and methods of use |
WO2003013571A1 (en) * | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
HUP0202719A3 (en) * | 2001-08-21 | 2006-01-30 | Pfizer Prod Inc | Pharmaceutical compositions for the treatment of female sexual dysfunctions |
KR20030027439A (en) * | 2001-09-28 | 2003-04-07 | 주식회사 엘지생명과학 | Melanocortin receptor agonists |
US6916812B2 (en) | 2001-10-09 | 2005-07-12 | Bristol-Myers Squibb Company | Alpha-aminoamide derivatives as melanocortin agonists |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
KR20030035589A (en) * | 2001-10-31 | 2003-05-09 | 주식회사 엘지생명과학 | Melanocortin receptor agonists |
KR20030035592A (en) * | 2001-10-31 | 2003-05-09 | 주식회사 엘지생명과학 | Melanocortin receptor agonists |
CA2466140C (en) | 2001-11-08 | 2011-02-01 | Ortho-Mcneil Pharmaceutical, Inc. | Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
US7319107B2 (en) | 2001-11-08 | 2008-01-15 | Johnson & Johnson Consumer Companies, Inc. | 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
CA2473036A1 (en) | 2002-01-23 | 2003-07-31 | Paul Leslie Ornstein | Melanocortin receptor agonists |
US20030207814A1 (en) * | 2002-02-04 | 2003-11-06 | Chiron Corporation | Novel guanidinyl derivatives |
US7026335B2 (en) | 2002-04-30 | 2006-04-11 | The Procter & Gamble Co. | Melanocortin receptor ligands |
EP1503761A1 (en) * | 2002-05-10 | 2005-02-09 | Neurocrine Biosciences, Inc. | Substituted piperazines as melanocortin receptor ligands |
WO2003099818A1 (en) | 2002-05-23 | 2003-12-04 | Chiron Corporation | Substituted quinazolinone compounds |
GB0213715D0 (en) | 2002-06-14 | 2002-07-24 | Syngenta Ltd | Chemical compounds |
US7105526B2 (en) | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
AU2003248888A1 (en) | 2002-07-09 | 2004-01-23 | Palatin Technologies, Inc. | Peptide composition for treatment of sexual dysfunction |
JP2006505531A (en) | 2002-09-11 | 2006-02-16 | メルク エンド カムパニー インコーポレーテッド | Piperazine urea derivatives as melanocortin-4 receptor agonists |
US7045527B2 (en) | 2002-09-24 | 2006-05-16 | Amgen Inc. | Piperidine derivatives |
US7132539B2 (en) | 2002-10-23 | 2006-11-07 | The Procter & Gamble Company | Melanocortin receptor ligands |
CN1330651C (en) | 2002-11-06 | 2007-08-08 | 安姆根有限公司 | Fused heterocyclic compounds |
US7323462B2 (en) | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US7160886B2 (en) | 2003-03-03 | 2007-01-09 | Merck & Co., Inc. | Acylated piperazine derivatives as melanocortin-4 receptor agonists |
EP1460073A1 (en) * | 2003-03-20 | 2004-09-22 | MyoContract Ltd. | Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
US7276520B2 (en) | 2003-03-26 | 2007-10-02 | Merck & Co., Inc. | Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
WO2004089307A2 (en) | 2003-04-04 | 2004-10-21 | Merck & Co. Inc. | Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
US7049323B2 (en) | 2003-04-25 | 2006-05-23 | Bristol-Myers Squibb Company | Amidoheterocycles as modulators of the melanocortin-4 receptor |
KR20060018217A (en) | 2003-05-23 | 2006-02-28 | 카이론 코포레이션 | Guanidino-substituted quinazolinone compounds as mc4-r agonists |
EP1669350B1 (en) | 2003-09-22 | 2012-02-29 | Msd K.K. | Piperidine derivatives |
KR20060105785A (en) | 2003-11-19 | 2006-10-11 | 카이론 코포레이션 | Quinazolinone compounds with reduced bioaccumulation |
US7420059B2 (en) | 2003-11-20 | 2008-09-02 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
GB0328907D0 (en) | 2003-12-12 | 2004-01-14 | Syngenta Participations Ag | Chemical compounds |
GB0328908D0 (en) | 2003-12-12 | 2004-01-14 | Syngenta Participations Ag | Chemical compounds |
GB0328906D0 (en) | 2003-12-12 | 2004-01-14 | Syngenta Participations Ag | Chemical compounds |
AU2005230864A1 (en) | 2004-03-29 | 2005-10-20 | Merck Sharp & Dohme Corp. | Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
WO2005097127A2 (en) | 2004-04-02 | 2005-10-20 | Merck & Co., Inc. | Method of treating men with metabolic and anthropometric disorders |
CA2574156A1 (en) | 2004-07-19 | 2006-02-23 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
CN1993320A (en) | 2004-08-06 | 2007-07-04 | 默克公司 | Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
KR101397913B1 (en) | 2005-05-30 | 2014-05-26 | 엠에스디 가부시키가이샤 | Novel piperidine derivative |
US20070021433A1 (en) | 2005-06-03 | 2007-01-25 | Jian-Qiang Fan | Pharmacological chaperones for treating obesity |
US8227476B2 (en) | 2005-08-03 | 2012-07-24 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
JPWO2007018248A1 (en) | 2005-08-10 | 2009-02-19 | 萬有製薬株式会社 | Pyridone compounds |
EP1921065B1 (en) | 2005-08-24 | 2010-10-20 | Banyu Pharmaceutical Co., Ltd. | Phenylpyridone derivative |
CA2621470A1 (en) | 2005-09-07 | 2007-03-15 | Banyu Pharmaceutical Co., Ltd. | Bicyclic aromatic substituted pyridone derivative |
RU2008116844A (en) | 2005-09-29 | 2009-11-10 | Мерк энд Ко., Инк. (US) | Acylated Spiropiperidine Derivatives as Modulators of the Melanocortin-4 Receptor |
CA2625877A1 (en) | 2005-10-18 | 2007-04-26 | Merck & Co., Inc. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
BRPI0617621A2 (en) | 2005-10-21 | 2011-08-02 | Novartis Ag | combination of organic compounds |
EP1944301A4 (en) | 2005-10-27 | 2012-01-04 | Msd Kk | Novel benzoxathiin derivative |
JP4371164B2 (en) | 2005-11-10 | 2009-11-25 | 萬有製薬株式会社 | Aza-substituted spiro derivatives |
EP1801098A1 (en) | 2005-12-16 | 2007-06-27 | Merck Sante | 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors |
US7858635B2 (en) | 2005-12-22 | 2010-12-28 | Vertex Pharmaceuticals Incorporated | Spiro compounds as modulators of muscarinic receptors |
JP2009527568A (en) * | 2006-02-22 | 2009-07-30 | バーテックス ファーマシューティカルズ インコーポレイテッド | Modulator of muscarinic receptor |
JP2009527569A (en) | 2006-02-22 | 2009-07-30 | バーテックス ファーマシューティカルズ インコーポレイテッド | Modulator of muscarinic receptor |
ES2571253T3 (en) | 2006-06-09 | 2016-05-24 | Synact Pharma Aps | Phenyl Pyrrole Aminoguanidine Derivatives |
EP2040706A2 (en) | 2006-06-29 | 2009-04-01 | Vertex Pharmceuticals Incorporated | Modulators of muscarinic receptors |
ATE456369T1 (en) | 2006-06-30 | 2010-02-15 | Boehringer Ingelheim Int | FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES |
EP2051712A2 (en) | 2006-08-15 | 2009-04-29 | Vertex Pharmceuticals Incorporated | Modulators of muscarinic receptors |
AU2007300627B2 (en) | 2006-09-22 | 2012-02-16 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
WO2008039863A2 (en) * | 2006-09-27 | 2008-04-03 | Braincells, Inc. | Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders |
AU2007300529A1 (en) * | 2006-09-27 | 2008-04-03 | Merck Sharp & Dohme Corp. | Acylated piperidine derivatives as melanocortin-4 receptor modulators |
JPWO2008038692A1 (en) | 2006-09-28 | 2010-01-28 | 萬有製薬株式会社 | Diaryl ketimine derivatives |
WO2008056687A1 (en) * | 2006-11-09 | 2008-05-15 | Daiichi Sankyo Company, Limited | Novel spiropiperidine derivative |
GB0624987D0 (en) | 2006-12-14 | 2007-01-24 | Acure Pharma Ab | Novel aminoguanidines as melanocortin receptor ligands |
EP1935420A1 (en) | 2006-12-21 | 2008-06-25 | Merck Sante | 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
AU2008233662B2 (en) | 2007-04-02 | 2012-08-23 | Msd K.K. | Indoledione derivative |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
MX354786B (en) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER and OTHER DISORDERS. |
CL2008002693A1 (en) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Use of flibanserin for the treatment of selected vasomotor symptoms of hot flashes, night sweats, mood swings, and irritability |
ES2453640T3 (en) | 2008-02-21 | 2014-04-08 | Janssen Pharmaceutica N.V. | Methods for the treatment of dermatological disorders |
JPWO2009110510A1 (en) | 2008-03-06 | 2011-07-14 | Msd株式会社 | Alkylaminopyridine derivatives |
CA2717384A1 (en) | 2008-03-28 | 2009-10-01 | Banyu Pharmaceutical Co., Ltd. | Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
EP2110374A1 (en) | 2008-04-18 | 2009-10-21 | Merck Sante | Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators |
AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US20110071129A1 (en) | 2008-06-19 | 2011-03-24 | Makoto Ando | Spirodiamine-diaryl ketoxime derivative |
ES2624828T3 (en) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others |
WO2010013595A1 (en) | 2008-07-30 | 2010-02-04 | 萬有製薬株式会社 | (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
CN102264228A (en) | 2008-10-22 | 2011-11-30 | 默沙东公司 | Novel cyclic benzimidazole derivatives useful for anti-diabetic agents |
US8329914B2 (en) | 2008-10-31 | 2012-12-11 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
US8759539B2 (en) | 2008-11-17 | 2014-06-24 | Merck Sharp & Dohme Corp. | Substituted bicyclic amines for the treatment of diabetes |
CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
CA2768577A1 (en) | 2009-07-23 | 2011-01-27 | Schering Corporation | Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
WO2011011506A1 (en) | 2009-07-23 | 2011-01-27 | Schering Corporation | Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
AU2010317842A1 (en) | 2009-11-16 | 2012-07-12 | Mellitech | [1,5]-diazocin derivatives |
CN102791701B (en) | 2009-12-30 | 2014-02-12 | 深圳信立泰药业股份有限公司 | 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase IV(DPP-IV) inhibitors |
CN102741252A (en) | 2010-02-05 | 2012-10-17 | 英特维特国际股份有限公司 | Spiroindoline compounds for use as anthelminthics |
JP2013520502A (en) | 2010-02-25 | 2013-06-06 | メルク・シャープ・エンド・ドーム・コーポレイション | Novel cyclic benzimidazole derivatives that are useful anti-diabetic drugs |
US8785634B2 (en) | 2010-04-26 | 2014-07-22 | Merck Sharp & Dohme Corp | Spiropiperidine prolylcarboxypeptidase inhibitors |
EP2568812B1 (en) | 2010-05-11 | 2016-10-26 | Merck Sharp & Dohme Corp. | Novel prolylcarboxypeptidase inhibitors |
EP2579873A4 (en) | 2010-06-11 | 2013-11-27 | Merck Sharp & Dohme | Novel prolylcarboxypeptidase inhibitors |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
WO2012100342A1 (en) | 2011-01-27 | 2012-08-02 | Université de Montréal | Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators |
EP2677869B1 (en) | 2011-02-25 | 2017-11-08 | Merck Sharp & Dohme Corp. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
EP2739626B1 (en) | 2011-08-04 | 2016-05-04 | Intervet International B.V. | Novel spiroindoline compounds |
WO2014022528A1 (en) | 2012-08-02 | 2014-02-06 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
EP2958562A4 (en) | 2013-02-22 | 2016-08-10 | Merck Sharp & Dohme | Antidiabetic bicyclic compounds |
EP2970119B1 (en) | 2013-03-14 | 2021-11-03 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2913737A1 (en) | 2013-06-05 | 2014-12-11 | Synergy Pharmaceuticals, Inc. | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
AU2014331812B2 (en) | 2013-10-09 | 2019-01-17 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines |
EP2881391A1 (en) | 2013-12-05 | 2015-06-10 | Bayer Pharma Aktiengesellschaft | Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof |
ES2901114T3 (en) | 2014-08-29 | 2022-03-21 | Tes Pharma S R L | Alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase inhibitors |
GB201519195D0 (en) | 2015-10-30 | 2015-12-16 | Heptares Therapeutics Ltd | CGRP Receptor Antagonists |
GB201519196D0 (en) | 2015-10-30 | 2015-12-16 | Heptares Therapeutics Ltd | CGRP Receptor Antagonists |
GB201519194D0 (en) | 2015-10-30 | 2015-12-16 | Heptares Therapeutics Ltd | CGRP receptor antagonists |
US10294214B2 (en) | 2016-06-07 | 2019-05-21 | Vanderbilt University | Positive allosteric modulators of human melanocortin-4 receptor |
US20180134667A1 (en) | 2016-10-14 | 2018-05-17 | TES Pharma S.r.I. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
WO2018106518A1 (en) | 2016-12-06 | 2018-06-14 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
WO2018118670A1 (en) | 2016-12-20 | 2018-06-28 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
MX2021005904A (en) | 2018-11-20 | 2021-09-08 | Tes Pharma S R L | INHIBITORS OF a-AMINO-ß-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE. |
EP4081525A4 (en) * | 2019-12-23 | 2024-01-10 | Crinetics Pharmaceuticals Inc | Spirocyclic piperidine melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578593A (en) * | 1992-12-11 | 1996-11-26 | Merck & Co., Inc. | Spiro piperidines and homologs promote release of growth hormone |
GB9415996D0 (en) * | 1994-08-08 | 1994-09-28 | Merck Sharp & Dohme | Therapeutic agents |
US5731408A (en) * | 1995-04-10 | 1998-03-24 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Peptides having potent antagonist and agonist bioactivities at melanocortin receptors |
-
1999
- 1999-06-10 WO PCT/US1999/013252 patent/WO1999064002A1/en not_active Application Discontinuation
- 1999-06-10 EP EP99930220A patent/EP1085869A4/en not_active Withdrawn
- 1999-06-10 JP JP2000553071A patent/JP2002517444A/en not_active Withdrawn
- 1999-06-10 CA CA002334551A patent/CA2334551A1/en not_active Abandoned
- 1999-06-10 AU AU46801/99A patent/AU742425B2/en not_active Ceased
Non-Patent Citations (2)
Title |
---|
MENG-HSIN C ET AL: "Analogs of the orally active growth hormone secretagogue l-162,752", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 6, no. 18, 17 September 1996 (1996-09-17), pages 2163 - 2168, XP004135677, ISSN: 0960-894X * |
See also references of WO9964002A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999064002A1 (en) | 1999-12-16 |
EP1085869A1 (en) | 2001-03-28 |
JP2002517444A (en) | 2002-06-18 |
AU4680199A (en) | 1999-12-30 |
AU742425B2 (en) | 2002-01-03 |
CA2334551A1 (en) | 1999-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1085869A4 (en) | Spiropiperidine derivatives as melanocortin receptor agonists | |
AU4928101A (en) | Spiropiperidine derivatives as melanocortin receptor agonists | |
IL147198A0 (en) | N-pyrazole a2a receptor agonists | |
IL147195A0 (en) | C-pyrazole a2a receptor agonists | |
AU5203999A (en) | Beta3-adrenergic receptor agonists | |
AU6497701A (en) | Melanocortin receptor agonists | |
HU9900120D0 (en) | Benzosulfone derivatives | |
IL140284A0 (en) | Adenosine derivatives | |
AP9801421A0 (en) | Novel erythromycin derivatives | |
GB9809664D0 (en) | a-Ketoamide derivatives | |
HUP0101753A3 (en) | Boring-tool | |
HK1034961A1 (en) | 2-phenylpyran-4-one derivatives | |
AU2001247227A1 (en) | 2-thioether a2a receptor agonists | |
EP1084142A4 (en) | Gpr35a receptor | |
AU4980999A (en) | A3 adenosine receptor antagonists | |
AU1100300A (en) | Piperidyloxadiazoles as dopamine receptor antagonists | |
GB9817179D0 (en) | Spiropiperidine derivatives as melanocortin receptor agonists | |
GB9819420D0 (en) | Novel receptor | |
EP1131335A4 (en) | 7tm receptor hlwar77 | |
EP1061912A4 (en) | Phenanthrofuran derivatives | |
EP1083909A4 (en) | hCEPR RECEPTOR | |
IL139276A0 (en) | Cyclohexenondioxthio chromanoyl derivatives | |
PL343639A1 (en) | Anchoring means, especially for balcony attachments | |
HK1042478A1 (en) | 2-oxo-2h-quinoline derivatives | |
GB9826491D0 (en) | Hydrazine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010111 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20010111;LT PAYMENT 20010111;LV PAYMENT 20010111;MK PAYMENT 20010111;RO PAYMENT 20010111;SI PAYMENT 20010111 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010817 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 07K 5/06 A, 7A 61K 31/47 B, 7A 61K 31/445 B, 7C 07D 217/26 B, 7C 07D 401/12 B, 7C 07D 471/04 B, 7A 61K 38/05 B |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20070226 |